Gates Foundation logo
Gates Foundation

Multiplex Platforms to Assess Indicators of Micronutrient Status, Inflammation and Infectious Disease

Funds teams building an improved multiplex lab test that measures micronutrient, inflammation and infectious-disease biomarkers together at low cost for population surveillance in low- and middle-income countries.

ClosedGates FoundationGlobal

Proposals are evaluated against detailed analytical targets -- sample volume, precision, sensitivity, accuracy and per-sample cost -- set out separately for the minimum-scope and optimistic-scope alternatives, with funding and project term tied to which alternative is proposed. Collaboration across institutions is encouraged since no single group is expected to hold all the needed expertise in met

This Grand Challenge wants a better multiplex immunoassay that measures micronutrient status alongside markers of inflammation and infection from a single small blood sample, extending coverage to vitamins B1, B2, B9 and B12 that current tests miss. It targets population-level surveillance in reference laboratories, not point-of-care clinical testing, and applicants can propose either a minimum-scope or an optimistic-scope version of the assay.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →

More from Gates Foundation

All grants from this funder →
Gates Foundation logo
Open

Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows

Gates Foundation · United States

Funds research teams building low-cost, simplified pathogen-sequencing workflows that bring the cost of sequencing a sample down to about US$1-10 for use in low- and middle-income countries.

Biotech
$300K – $800KSep'26
Gates Foundation logo
Between cycles

Gates Foundation Grand Challenges — Portfolio

Gates Foundation · United States

Supports global health innovators through rotating challenge themes in diagnostics, nutrition, and development-focused technologies for public impact.

BiotechMedtech+2
$800K
Gates Foundation logo
Closed

Estimating the Global Burden of Diarrheal Diseases

Gates Foundation · United States

Supports teams producing country-level estimates of major diarrheal diseases to inform global health planning and child health priorities.

BiotechMedtech
$1.5M
Gates Foundation logo
Closed

Grand Challenges — Breakthrough Innovations to Reduce the Cost of Severe Acute Malnutrition Treatment

Gates Foundation · United States

Funds global teams developing system-level innovations that reduce the total cost of treating severe acute malnutrition in Sub-Saharan Africa and South Asia.

MedtechAI+2
$1.5M
Gates Foundation logo
Closed

Grand Challenges — Cost-Reducing Innovations for Ready-to-Use Therapeutic Food

Gates Foundation · United States

Funds global teams developing innovations in protein, lipids, packaging, and manufacturing that reduce the ex-factory unit cost of ready-to-use therapeutic food by at least 30%.

Food TechAdvanced Manufacturing+3
$1.5M
Gates Foundation logo
Closed

Grand Challenges — Placental and Gut Inflammation Interventions for Fetal Growth

Gates Foundation · United States

Funds global teams developing drug, biologic, dietary, or microbiome-based interventions that target placental and gut inflammatory pathways to improve fetal growth outcomes in low-income countries.

BiotechMedtech+1
$1M
National Institutes of Health logo
Open

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment

NIH · United States

Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.

BiotechMedtech
$499KJan'28
National Institutes of Health logo
Open

Molecular Imaging of Inflammation in Cancer

🇺🇸NIH · United States

Funds molecular imaging that shows how inflammation and cancer interact inside a living body, rather than in a dish or a slide.

MedtechBiotech+1
$500KJan'28
National Institutes of Health logo
Open

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis

NIH · United States

Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.

BiotechMedtech
$500KJan'27
National Institutes of Health logo
Open

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research

🇺🇸NIH · United States

Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.

BiotechMedtech
$350KDec'27
National Center for Advancing Translational Sciences logo
Open

NCATS Preclinical Proof of Concept Studies for Rare Diseases

🇺🇸NCATS · United States

Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.

BiotechMedtech+1
$275KJun'27
National Center for Advancing Translational Sciences logo
Open

NCATS Clinical Trial Readiness for Rare Diseases

🇺🇸NCATS · United States

Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.

BiotechMedtech+1
$275KFeb'27